731 related articles for article (PubMed ID: 17515463)
1. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
3. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
5. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
7. [Effects of injuries pulmonary arterial endothelial cell induced by endotoxin on proliferation of pulmonary artery smooth muscle cells and interference effect of bone morphogenetic protein-2].
Pei L; Shan SM; Sun XY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):40-5. PubMed ID: 18346379
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
9. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary arterial hypertension and BMP system abnormality].
Otsuka F
Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
[TBL] [Abstract][Full Text] [Related]
11. RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints.
Mamidipudi V; Dhillon NK; Parman T; Miller LD; Lee KC; Cartwright CA
Oncogene; 2007 May; 26(20):2914-24. PubMed ID: 17072338
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.
Upton PD; Long L; Trembath RC; Morrell NW
Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
[TBL] [Abstract][Full Text] [Related]
14. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension.
Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC
Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866
[TBL] [Abstract][Full Text] [Related]
15. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
[TBL] [Abstract][Full Text] [Related]
16. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
17. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
Orriols M; Gomez-Puerto MC; Ten Dijke P
Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.
Wong WK; Knowles JA; Morse JH
Am J Respir Cell Mol Biol; 2005 Nov; 33(5):438-46. PubMed ID: 16002577
[TBL] [Abstract][Full Text] [Related]
19. BMPRII deficiency impairs apoptosis via the BMPRII-ALK1-BclX-mediated pathway in pulmonary arterial hypertension.
Chowdhury HM; Sharmin N; Yuzbasioglu Baran M; Long L; Morrell NW; Trembath RC; Nasim MT
Hum Mol Genet; 2019 Jul; 28(13):2161-2173. PubMed ID: 30809644
[TBL] [Abstract][Full Text] [Related]
20. MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling.
Zhang Y; Peng B; Han Y
Biomed Pharmacother; 2018 Jul; 103():1279-1286. PubMed ID: 29864909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]